Real-world Medicare Healthcare Costs of Patients with Dupuytren’s Contracture Treated with Collagenase or Fasciectomy
Background:. Our study aimed to compare real-world healthcare resource utilization (HRU) and healthcare cost (HC) of Medicare-insured patients (≥65 years old) with Dupuytren’s contracture (DC) treated with Clostridium histolyticum (collagenase) or fasciectomy. Methods:. DC patients treated with coll...
Main Authors: | Vladimir Zah, DPhil, Filip Stanicic, MSc, Jane Ruby, PhD, Djurdja Vukicevic, MD, PhD, David Hurley, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-08-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004480 |
Similar Items
-
Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis
by: Zah V, et al.
Published: (2020-11-01) -
Comparison between Collagenase Injection and Partial Fasciectomy in the Treatment of Dupuytren’s Contracture
by: Tay, T.K.W., et al.
Published: (2015) -
111. A Long-term Comparison of Collagenase versus Fasciectomy in the Treatment of Dupuytren’s Contracture
by: Cyrus S. Steppe, BA, et al.
Published: (2023-05-01) -
Cost per Episode of Care With Collagenase Clostridium histolyticum Versus Fasciectomy for Dupuytren Contracture: A Real-World Claims Database Analysis
by: Stephen B. Camper, MS, PhD, et al.
Published: (2019-04-01) -
Abstract: Digital Sympathectomy at the Time of Fasciectomy for Dupuytren’s Contracture
by: Jesse R. Smith, MD, MS, et al.
Published: (2017-09-01)